Status:
COMPLETED
Pulmicort Asthma Prevention (Post-PAC)
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
Up to 6 years
Phase:
NA
Brief Summary
This prospective study will evaluate the feasibility of the defined decision tree for the treatment of asthmatic young children. Children who develop episode (=3 consecutive days) of any troublesome l...
Eligibility Criteria
Inclusion
- Children form the COPSAC/PAC study with episodes of troublesome respiratory symptoms. Episodes are defined as 3 consecutive days of any troublesome lower respiratory symptoms.
Exclusion
- Differential diagnoses including at least a chest x-ray and sweat test.
Key Trial Info
Start Date :
July 1 2001
Trial Type :
INTERVENTIONAL
End Date :
June 1 2006
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00233584
Start Date
July 1 2001
End Date
June 1 2006
Last Update
January 14 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Copenhagen, Denmark